NUEVOCOR

HQ - Singapore

Summary

Nuevocor is a preclinical-stage biopharmaceutical company based in Singapore that is focused on developing gene therapy-based treatments for cardiovascular diseases, specifically genetic cardiomyopathies.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 34 M

Avg. Deal Size£ 34 M

Market Context

Senior Management

Yann Chong Tan
Co-Founder and CEO